The inventions described herein relate to improved bioreactors and methods of use to more efficiently grow microorganisms.
Bioreactors are used to grow aerobic organisms used in products such as medicines, vaccines, cosmetics, and many others.
The inventions described herein may be used to increase oxygen levels in bioreactors with the intent of accelerating the growth rate of the microorganisms in said reactors.
In prior bioreactor designs, the sole option that the devices operators could use to increase the efficiency of oxygen transfer was to increase the rotational speed of the bioreactor's agitators. This control function is limited by the shear that the agitators create as they rotate. At a certain point, the shear forces become so great that it ruptures the cells growing in the bioreactor.
The current inventions teach the use of a centrifuge to enhance sedimentation of solid particles suspended in the fluid medium contained within a bioreactor. The supernatant from the centrifugal separator then flows through a venturi.
Bernoulli demonstrated the eponymous principal: the faster a fluid flows, the lower the pressure within the fluid becomes. This low pressure can be used to pull a gas (air or oxygen) into the venturi and mix the gas with the fluid flowing through the venturi. High shear forces within the venturi break the incoming gas into small bubbles.
In U.S. Pat. No. 10,246,359, there is described a derivation of this relationship:
Rt∝1/(Bd)2
Where Rt is the rate of gas transport from the interior of a submerged bubble to its surface and Bd is the diameter of the bubble. This inverse square proportionality demonstrates that decreasing the size of submerged bubbles is a very effective means of increasing gas transfer to the liquid phase.
After a gas molecule reaches the submerged bubble's surface it must dissolve into the liquid phase to complete the gas-liquid transport process. Bioreactor designers use a performance metric, kLa, to guide process and bioreactor design. In this metric, a is the aggregate submerged bubble surface area, and kL is the liquid side gas mass transfer coefficient.
Unpacking kL will illustrate how the inventions described herein are an improvement of current bioreactor designs. Several parameters are incorporated in the current understanding of kL. Some of these are: agitator geometry, agitator power input, agitation tip speed, and gas sparger design. All these parameters are eliminated in this novel invention by using a venturi to sparge gas into a bioreactor. With a venturi, the gas transfer rate into the bioreactor process depends on the gas concentration gradient across the gas-liquid interface. The primary parameters that influence this gradient are:
With these insights, it is therefore possible to write a new definition of kLa that pertains to the operation of the novel bioreactors described in this invention:
kLa=F/(Bd)2
Where F is a function of Bc, Sc, and Vl.
The inventions described herein avoid the problems of the prior art by, among other things, separating the cells from the fluid before the fluid is aerated. In one embodiment, a bioreactor comprises a mixing tank containing cells to be cultured in a media. Paddle agitators are optionally attached to suitable crossbars and shafting is provided within the mixing tank to rotate the agitator assembly to keep the cells in suspension. A pump is coupled to a mixing tank to withdraw fluid and deliver it to an extractor that separates the cells from media by centrifugation. The cells collected at the periphery of this extractor, due to centrifugation, are fed back to the mixing tank, whereas the supernatant fluid left is pumped into a venturi that facilitates aeration of the supernatant fluid. The aerated supernatant fluid then flows back into the mixing tank. Additionally, in the proposed bioreactor the entrance point of the aerated fluid to the mixing tank may be such that the solids are kept in suspension in the mixing tank, thereby obviating the need for prior art agitators. The connections between the mixing tank, extractor and venturi are made by using suitable pumps, valves and pipes.
The most common bioreactor design is a continuously stirred tank reactor (CSTR). Both batch reactors and continuous flow-through reactors are in use. In a batch process, a bioreactor is partially filled with media. The cells are then inoculated and grow until the nutrients are consumed, and then harvested. A fed-batch process is similar to a batch process, except fresh nutrients are introduced to the bioreactor as required, which prevents the depletion of nutrients and provides for additional cell growth. Another process, known as perfusion, is used to remove unwanted compounds, allowing the process to last longer than fed-batch. Diaphragm or peristaltic pumps may be used in conjunction flow filters. Because of this waste flow of media out of the bioreactor there is a constant fresh feed of media into the bioreactor to maintain volume. However, this process is not continuous, as the bioreactor does not reach steady state as the cells grow and will reach a limit in cell density. A continuous process is when the bioreactor substantially reaches a steady state, where there is a continuous stream of feed into the bioreactor and a continuous outflow of product out of the bioreactor. The goal is to manufacture the product at a constant rate with little or no downtime between batches.
A batch reactor is shown in
Bioreactor 200 as described herein solves the limitations of the prior art as described above. In one embodiment illustrated in
In one embodiment, shown in step 404, pump 205 pulls a stream of fluid from bioreactor mixing tank 201 and delivers this fluid to a centrifugal extractor 206. In step 406, a centrifuge motor 207 is engaged that causes the contents of the centrifugal extractor 206 to rotate. Centrifugal force causes the solids carried in the fluid to accumulate at the periphery of the centrifugal extractor 206. This process is an enhanced form of sedimentation. It is inherently low shear and kills the live cells at a much lower rate than traditional bioreactor aeration methods. In step 408, the solids are selectively deposited back into bioreactor mixing tank 201 by controlling the opening and closing of centrifuge valve 208.
In step 410, the remaining fluid (without solids) in centrifugal extractor 206 may be removed from the centrifugal extractor 206 by fluid pump 209 and in step 412, delivered to venturi valve 210, which controls the flow of this fluid into a venturi 211 disposed in the bioreactor mixing tank 201. Venturi 211 is connected to an air pipe. Venturi 211 creates a vacuum that draws purified air through the air pipe, mixing the air with the fluid traveling through venturi 211, and aerating the fluid in step 414. Air pipe valve 212 controls the flow of purified air into venturi 211. The venturi 211 creates a low pressure zone that draws in purified air and mixes this air with the fluid flowing through the venturi 211. The high shear forces in the venturi 211 break the air in to small bubbles, which are highly efficient in aerating the fluid. The venturi 211 can be similar to the one described in U.S. Pat. No. 10,604,429, or it can be any type of venturi 211 that has a gradually tapering inflow section that restricts the flow area of the fluid flowing through the venturi 211. This restriction accelerates the fluids flow velocity. The fluids flow velocity is then decelerated by a gradually tapering outflow section that increases the fluid flow area.
In step 416, aerated fluid then delivered back into bioreactor mixing tank 201 via aerated fluid pipe 213. Agitators 214, when optionally coupled to a shaft 215 and disposed within bioreactor mixing tank 201, are not needed to assist oxygenation of the contents of tank. Rather, if included, they may be selectively moved by motor 216 at a speed sufficient to keep the solids in bioreactor mixing tank 201 in suspension, but low enough to not damage the cells. The flow of air out of bioreactor mixing tank 201 is controlled by air valve 217. In this embodiment, the aeration system is designed so that the fluid flow and the air flow can be controlled separately and independently. These controls can be operated manually. Alternatively, suitable sensors and electronic controllers can be used to operate the air and fluid control valves, including through automatic programming.
In yet another embodiment illustrated in
The remaining fluid (without solids) may be removed from the centrifugal extractor 306 by fluid pump 309. Venturi valve 310 controls the flow of this fluid into a venturi 311, which is connected to an air pipe. Venturi 311 creates a vacuum that draws purified air through the air pipe, mixing the air with the fluid traveling through venturi 311, and aerating the fluid. Air pipe valve 312 controls the flow of purified air into venturi 311. The flow of air out of bioreactor mixing tank 301 is controlled by air valve 314. In this embodiment, though, aerated fluid then flows back into bioreactor mixing tank 301 via aerated fluid pipe 313, which has a different entrance point on bioreactor mixing tank 301 than the one illustrated in
While the invention has been described with reference to particular embodiments, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the scope of the invention.
Therefore, it is intended that the invention not be limited to the particular embodiments disclosed as the best mode contemplated for carrying out this invention, but that the invention will include all embodiments falling within the scope and spirit of the appended claims.
This application claims priority to, and incorporates by reference as if fully set forth herein, U.S. Provisional Application Ser. No. 63/168,577, which was filed on Mar. 31, 2021.
Number | Date | Country | |
---|---|---|---|
63168577 | Mar 2021 | US |